Table 3 Characteristics of patients who did or did not develop contrast-induced nephropathy
No CIN | CIN | p value | |
|---|---|---|---|
Number of CT scans | 153 (72.5 %) | 58 (27.5 %) | |
Age (years) | 64 (13) | 69 (10) | <0.01 |
Male gender | 88 (57.5 %) | 37 (63.8 %) | 0.41 |
Diabetes mellitus | 22 (14.4 %) | 10 (17.2 %) | 0.61 |
Heart failure | 6 (3.9 %) | 5 (8.6 %) | 0.18 |
Sepsis | 41 (26.8 %) | 15 (25.9 %) | 0.89 |
Baseline GFR < 60 mL/min | 52 (34.0 %) | 44 (75.9 %) | <0.01 |
Haemoglobin (mmol/L) | 6.6 (1.1) | 6.2 (0.88) | 0.01 |
APACHE II score | 19.5 (7.9) | 22.8 (8.9) | <0.01 |
APACHE IV score | 74.5 (29.1) | 92.6 (28.9) | <0.01 |
SOFA day 1 | 8.0 (7.0) | 5.0 (4.0) | <0.01 |
SOFA day 4 | 11.0 (6.0) | 4.0 (3.0) | <0.01 |
Fluid balance (mL/24 h) | 2180 (4566) | 3488 (7251) | 0.03 |
Aminoglycoside (single-dose) use | 5 (3.3 %) | 7 (12.1 %) | 0.02 |
Norepinephrine use | 32 (20.9 %) | 22 (37.9 %) | 0.01 |
Prophylactic therapy | 29 (19.0 %) | 19 (32.8 %) | 0.03 |